The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO GI 2025 | South-East England Network’s experience of reflex molecular biomarker testing in colorectal cancer
Wing Kin Liu, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses the South-East England Network’s experience of reflex molecular biomarker testing in colorectal cancer. In this study of 107 patients, only one patient had molecular information ready for their first multidisciplinary team meeting, and just 20% had results available for their first oncology appointment, potentially preventing optimal treatment selection for initial therapy cycles. This interview took place at the European Society for Medical Oncology (ESMO) Gastrointestinal Cancer 2025 Congress in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
